Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion

Laryngoscope

Volumn 119, Issue 8, 2009, Pages 1510-1517

  Worden, Francis P ^a,c   Moyer, Jeffrey ^a   Lee, Julia S ^a   Taylor, Jeremy M G ^a   Urba, Susan G ^a   Eisbruch, Avraham ^b   Teknos, Theodoros N ^a   Chepeha, Douglas B ^a   Prince, Mark E ^a   Hogikyan, Norman ^a   Lassig, Amy Anne D ^a   Emerick, Kevin ^a   Mukherji, Suresh ^a   Hadjiski, Lubomir ^a   Tsien, Christina I ^b   Miller, Tamara H ^a   Wallace, Nancy E ^a   Mason, Heidi L ^a   Bradford, Carol R ^a   Wolf, Gregory T ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RELAPSE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HISTOLOGY; HUMAN; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNGECTOMY; LARYNGOSCOPY; LARYNX CARCINOMA; LARYNX CARTILAGE; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; ORGAN PRESERVATION; OTOTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; POSTOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SENSORY NEUROPATHY; SIDE EFFECT; SPEECH; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TINNITUS; TRACHEOSTOMY; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 68849118020     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20294     Document Type: Article

References (21)

1. Forastiere AA, Goepfert H, Manor M, et al. Concurrent che- moradiotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349: 2091-2098.
2. Yuen A, Medina JE, Goepfert H, et al. Management of stage T3 and T4 glottic carcinomas. Am J Surg 1984;148: 467-472.
3. Hinerman RW, Mendenhall WM, Amdur RJ, et al. Carcinoma of the supraglottic larynx: treatment alone or with planned neck dissection. Head Neck 2002;24:456-467
4. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-1690.
5. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 2006;24:593-598.
6. Worden FP, Wolf GT, Eisbruch A, et al. Chemo-selection of patients for organ preservation in advanced laryngeal cancer: failure of chemotherapy as the sole treatment for complete histologic responders to neoadjuvant chemotherapy. J Clin Oncol 2006;24(suppl):18S, 5560.
7. American Joint Committee on Cancer. In: Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual and Handbook. 6th ed. New York, NY: Springer- Verlag; 2002:301-346.
8. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216. (Pubitemid 30099779)
9. Eisbruch A, Marsh LH, Martel MK, et al. Comprehensive irradiation of head and neck cancer using conformal mul- tisegmental fields: assessment of target coverage and noninvolved tissue sparing. Int J Radiat Oncol Biol Phys 1998;41:559-568.
10. List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990;66: 564-569.
11. Dropkin MJ. Body image and quality of life after head and neck cancer. Semin Oncol 1988;15:61-69.
12. Knab RB, Salama JK, Stenson KM, et al. Definitive chemo- radiation for T4 laryngeal squamous cell carcinoma. Int J Rad Onc Biol Phys 2006;66(suppl):S14, 24.
13. Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994;86: 265-272.
14. Domenge C, Hill C, Lefebvre JL, et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC). Br J Cancer 2000;83:1594-1598.
15. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta- Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955.
16. Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005;23:8636-8645.
17. Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705-1715.
18. Bourhis J, Le Maitre A, Baujat B, Audry H, Pignon JP. Individual patients' data meta-analyses in head and neck cancer. Curr Opin Oncol 2007;19:188-194. (Pubitemid 46597476)
19. Jordhoy MS, Fayers P, Loge JH, et al. Quality of life in advanced cancer patients: the impact of sociodemographic and medical characteristics. Br J Cancer 2001;85: 1478-1485.
20. Movsas B, Scott C, Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: a radiation therapy oncology group (RTOG) analysis. Int J Radiat Oncol Biol Phys 2006;65:830-835.
21. Cheng S, Terrell J, Bradford C, et al. Variables associated with feeding tube placement in head and neck cancer. Arch Otolaryngol Head Neck Surg 2006;132:1-8.